Literature DB >> 9950184

Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

D Falkenhagen1, W Strobl, G Vogt, A Schrefl, I Linsberger, F J Gerner, M Schoenhofen.   

Abstract

The removal of albumin bound substances has gained increasing interest in different diseases, especially in acute and chronic liver disease. Therefore, a new system, the fractionated plasma separation and adsorption (FPSA) system, was developed based on combined membrane and adsorbent blood purification techniques. The most important contribution to the FPSA system was the development of a new polysulfone hollow-fiber filter, which is characterized by a sieving coefficient of 0.89 for human serum albumin (HSA) but only of 0.17 for fibrinogen, and 0 (zero) for IgM immunoglobulins. Using a closed filtrate circuit connected to the new polysulfone filter which integrates 1 or 2 adsorption columns and also a high flux dialyzer adapted to a dialysis machine, the FPSA system opens excellent possibilities for the relatively specific removal of albumin bound substances from the blood such as albumin bound bilirubin or even tryptophan. In comparison to other systems (for example, the Molecular Adsorbent Recirculating System [MARS] and albumin dialysis systems), the FPSA system enables much higher elimination of strongly bound albumin substances. The first clinical investigations have recently started based on a modified dialysis machine designed with all necessary safety measures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950184     DOI: 10.1046/j.1525-1594.1999.06292.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  25 in total

Review 1.  [Liver replacement therapy. Reliable indications in acute liver failure].

Authors:  K Rifai; M Ott; M M Bahr; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  Prospects for extracorporeal liver support.

Authors:  R Jalan; S Sen; R Williams
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Removal selectivity of Prometheus: a new extracorporeal liver support device.

Authors:  Kinan Rifai; Thomas Ernst; Ulrich Kretschmer; Hermann Haller; Michael Peter Manns; Danilo Fliser
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

4.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 5.  [Extracorporeal therapies in hepatic diseases].

Authors:  D Jarczak; G Braun; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-08       Impact factor: 0.840

6.  Liver dialysis in acute-on-chronic liver failure: current and future perspectives.

Authors:  Rakhi Maiwall; Jaswinder Singh Maras; Suman Lata Nayak; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-04-24       Impact factor: 6.047

Review 7.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

Review 8.  [Acute liver failure. Current aspects of diagnosis and therapy].

Authors:  M Bauer; M Paxian; A Kortgen
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

Review 9.  Role of artificial liver support in hepatic encephalopathy.

Authors:  V Stadlbauer; G A K Wright; R Jalan
Journal:  Metab Brain Dis       Date:  2008-12-21       Impact factor: 3.584

10.  Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).

Authors:  Ludwig Kramer; Edith Bauer; Peter Schenk; Rudolf Steininger; Marion Vigl; Reinhold Mallek
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.